Speaker | Title |
---|---|
Joseph Wu, MD, PhD (Stanford University)
|
Patient-derived Induced Pluripotent Stem Cells in Cardiovascular Precision Medicine |
Karen Reue, PhD (University of California Los Angeles)
|
Mouse Models for Pharmacogenomic Discovery |
Nadav Ahituv, PhD (University of California San Francisco)
|
Functional Characterization of Gene Regulatory Elements |
Cheryl Cui (Massachusetts Institute of Technology)
|
Massively Parallel Combinatorial Genetic Perturbation Screening with CRISPR- Cas9 in Human Cells |
Lon Cardon, PhD (GlaxoSmithKline)
|
Applications of Human Genetics in Drug Discovery to Present and Future Indications |
Marisa Wong Medina, PhD (Children’s Hospital Oakland Research Institute)
|
Long Noncoding RNA in Statin Pharmacogenomics |
Nancy Cox, PhD (Vanderbilt University) |
Data Integration Approaches to Novel Therapeutics |
Marylyn Ritchie, PhD (Penn State University)
|
Methods of Integrating Data to Uncover Pharmacogenomic Phenotypes |
Olga Troyanskaya, PhD (Princeton University)
|
Tissue-specific Integrated View of Complex Human Disease |
|
Panel Discussion: Issues for Clinical Implementation of Pharmacogenomic Testing |
Stuart Scott, PhD (Icahn School of Medicine at Mount Sinai)
|
Influence of Ancestry on Pharmacogenomic Traits |
Silvia Fuselli, PhD (University of Ferrara)
|
Evolution of Drug Metabolizing Enzymes |
Sarah Tishkoff, PhD (University of Pennsylvania)
|
Impact of Ancestry and Natural Selection on African Genetic Diversity |
Geoffrey H. Siwo, PhD (IBM Research Africa)
|
Unexpected Impacts of Evolutionary Selection on Genes Relevant for Targeted Therapeutics in Cancer |